HIVE Blockchain Technologies (CVE:HIV) Upgraded by Northland Capmk to “Strong-Buy”

Posted by on Sep 20th, 2024

HIVE Blockchain Technologies (CVE:HIV – Get Free Report) was upgraded by equities researchers at Northland Capmk to a “strong-buy” rating in a note issued to investors on Thursday, Zacks.com reports.

Separately, HC Wainwright upgraded shares of HIVE Blockchain Technologies from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 15th.

Check Out Our Latest Stock Report on HIVE Blockchain Technologies

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies (CVE:HIV – Get Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported C($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C($0.10) by C($0.01). The company had revenue of C$44.11 million for the quarter, compared to analyst estimates of C$43.64 million.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.

Featured Articles

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.